These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31402969)

  • 1. Stereotactic body radiotherapy versus conventional radiotherapy for early-stage small cell lung cancer.
    Newman NB; Sherry AD; Byrne DW; Osmundson EC
    J Radiat Oncol; 2019 Jun; 8(2):239-248. PubMed ID: 31402969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic ablative radiation therapy versus conventionally fractionated radiation therapy for stage I small cell lung cancer.
    Verma V; Hasan S; Wegner RE; Abel S; Colonias A
    Radiother Oncol; 2019 Feb; 131():145-149. PubMed ID: 30773182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer.
    Andruska N; Fischer-Valuck BW; Agabalogun T; Carmona R; Brenneman RJ; Huang Y; Gay HA; Michalski JM; Baumann BC
    Clin Genitourin Cancer; 2022 Apr; 20(2):123-131. PubMed ID: 35086762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
    Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
    Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
    Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
    Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database.
    Xiang M; Heestand GM; Chang DT; Pollom EL
    Radiother Oncol; 2020 Feb; 143():101-107. PubMed ID: 32044168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid.
    Wegner RE; Abel S; Horne ZD; Hasan S; Colonias A; Verma V
    Lung Cancer Manag; 2019 Aug; 8(3):LMT14. PubMed ID: 31807142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
    Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
    Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer.
    Ma SJ; Serra LM; Bartl AJ; Han HR; Fekrmandi F; Iovoli AJ; Prezzano KM; Hermann GM; Yu H; Singh AK
    J Radiother Pract; 2022 Sep; 21(3):403-410. PubMed ID: 36016862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer-patterns of care and overall survival.
    Dohopolski MJ; Glaser SM; Vargo JA; Balasubramani GK; Beriwal S
    J Gastrointest Oncol; 2017 Oct; 8(5):766-777. PubMed ID: 29184680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
    Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
    Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.
    Foster CC; Rusthoven CG; Sher DJ; Feldman L; Pasquinelli M; Spiotto MT; Koshy M
    Lung Cancer; 2019 Apr; 130():162-168. PubMed ID: 30885339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
    von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
    Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis.
    Dong B; Zhu X; Jin J; Chen Y; Ying H; Chen Y; Lu F; Shen W; Wang J; Chen M
    J Thorac Dis; 2020 Oct; 12(10):5934-5954. PubMed ID: 33209426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer.
    Wu G; Baine MJ; Zhao N; Li S; Li X; Lin C
    BMC Cancer; 2019 Oct; 19(1):977. PubMed ID: 31640607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
    Nanda RH; Liu Y; Gillespie TW; Mikell JL; Ramalingam SS; Fernandez FG; Curran WJ; Lipscomb J; Higgins KA
    Cancer; 2015 Dec; 121(23):4222-30. PubMed ID: 26348268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma.
    Jiang W; Haque W; Verma V; Butler EB; Teh BS
    Acta Oncol; 2019 Sep; 58(9):1259-1266. PubMed ID: 31237185
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
    Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
    Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer.
    Wang SC; Ting WC; Chang YC; Yang CC; Lin LC; Ho HW; Chu SS; Lin YW
    Front Oncol; 2020; 10():814. PubMed ID: 32547949
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer.
    Verma V; McMillan MT; Grover S; Simone CB
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):146-154. PubMed ID: 27843029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.